V020-3703 Screening compound: 2-{1-[(4-chlorophenyl)sulfonyl]-4-piperidyl}-6-methyl-N~3~-(3-phenylpropyl)nicotinamide

V020-3703 Screening compound: 2-{1-[(4-chlorophenyl)sulfonyl]-4-piperidyl}-6-methyl-N~3~-(3-phenylpropyl)nicotinamide
V020-3703 Screening compound: 2-{1-[(4-chlorophenyl)sulfonyl]-4-piperidyl}-6-methyl-N~3~-(3-phenylpropyl)nicotinamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-3703
2-{1-[(4-chlorophenyl)sulfonyl]-4-piperidyl}-6-methyl-N~3~-(3-phenylpropyl)nicotinamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-3703

Molecular Formula

C27H30ClN3O3S (C27 H30 ClN3 O3 S)

Compound Name

2-{1-[(4-chlorophenyl)sulfonyl]-4-piperidyl}-6-methyl-N~3~-(3-phenylpropyl)nicotinamide

IUPAC name

2-[1-(4-chlorobenzenesulfonyl)piperidin-4-yl]-6-methyl-N-(3-phenylpropyl)pyridine-3-carboxamide

SMILES

Cc1ccc(C(NCCCc2ccccc2)=O)c(C(CC2)CCN2S(c(cc2)ccc2Cl)(=O)=O)n1

InChI

InChI=1S/C27H30ClN3O3S/c1-20-9-14-25(27(32)29-17-5-8-21-6-3-2-4-7-21)26(30-20)22-15-18-31(19-16-22)35(33,34)24-12-10-23(28)11-13-24/h2-4,6-7,9-14,22H,5,8,15-19H2,1H3,(H,29,32)

InChI Key

CMDUHRMGJULPPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19929115

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

512.07

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.278

Distribution Coefficient, logD

6.277

Water Solubility, LogSw

-5.98

Polar Surface Area

65.125

Acid Dissociation Constant (pKa)

12.49

Base Dissociation Constant (pKb)

4.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V020-3703 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V020-3703 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-3703?
Check Price and Availability of V020-3703, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-3703 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-3703
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-3703
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-3703 available by request